| Schedule of Reconciliations of Income Tax Expenses |
Schedule
of Reconciliations of Income Tax Expenses
| | |
August 31, 2026 | | |
February 28, 2026 | |
| | |
(unaudited) | | |
| |
| Loss before income tax expenses | |
$ | (6,989,552 | ) | |
$ | (7,041,333 | ) |
| Income tax credit computed at various statutory income tax rate (15% to 25%) | |
| (994,152 | ) | |
| (440,899 | ) |
| Reconciling items: | |
| | | |
| | |
| Tax incentive – R&D Credit | |
| — | | |
| (69,940 | ) |
| Income not subject to tax in China | |
| (19,847 | ) | |
| (38,590 | ) |
| Change in fair value of derivative liabilities | |
| 248,686 | | |
| — | |
| Non-deductible expenses | |
| 715,313 | | |
| 549,429 | |
| Total provision for (benefit from) income tax | |
$ | — | | |
$ | — | |
|
| Schedule of Deferred Tax Assets |
Schedule of Deferred Tax Assets
| | |
August 31, 2026 | | |
February 28, 2026 | |
| | |
(unaudited) | | |
| |
| Deferred tax assets | |
| | | |
| | |
| Net operating losses carry forward | |
$ | 4,369,675 | | |
$ | 4,244,187 | |
| Accruals and reserves | |
| 8,399,506 | | |
| 7,121,646 | |
| Lease liability | |
| 38,650 | | |
| 20,160 | |
| Total deferred tax assets | |
| 12,807,831 | | |
| 11,385,993 | |
| Less: Valuation allowance | |
| (5,683,377 | ) | |
| (4,389,425 | ) |
| Total deferred tax assets, net of valuation allowance | |
| 7,124,454 | | |
| 6,996,568 | |
| Deferred tax liabilities | |
| | | |
| | |
| Right-of-use asset | |
| (18,361 | ) | |
| (18,002 | ) |
| Total deferred tax liabilities | |
| (18,361 | ) | |
| (18,002 | ) |
| | |
| | | |
| | |
| Net deferred tax assets (liabilities) | |
$ | 7,106,093 | | |
$ | 6,978,566 | |
|